SCHEMBL2216212

SCHEMBL2216212

O=C(CCC(=O)c1cccs1)c1cccs1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 1.00
LMNA P02545 2/20 1.00
MEN1 O00255 2/20 1.00
KMT2A Q03164 2/20 1.00
NPC1 O15118 2/20 1.00
RAB9A P51151 2/20 1.00
POLB P06746 1/20 1.00
GSK3B P49841 1/20 0.69
HPGD P15428 4/20 0.69
L3MBTL1 Q9Y468 2/20 0.69
PKM P14618 1/20 0.69
TSHR P16473 1/20 0.69
MAPK1 P28482 1/20 0.69
HTT P42858 1/20 0.69
HSD17B10 Q99714 1/20 0.69
CTNNB1 P35222 5/20 0.68
WNT3A P56704 4/20 0.68
CES2 O00748 1/20 0.62
CES1 P23141 1/20 0.62
HDAC1 Q13547 1/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL759462 0.92 ALDH1A1 (0.84) ALDH1A1LMNAMEN1KMT2ANPC1
SCHEMBL22721189 0.91 ALDH1A1 (0.83) ALDH1A1LMNAMEN1KMT2ANPC1
SCHEMBL18755474 0.90 ALDH1A1 (0.81) ALDH1A1LMNAMEN1KMT2ANPC1
Hydrochloric Acid SCHEMBL1373347 0.90 ALDH1A1 (0.81) ALDH1A1LMNAMEN1KMT2ANPC1
SCHEMBL5188799 0.90 ALDH1A1 (0.81) ALDH1A1LMNAMEN1KMT2ANPC1
SCHEMBL5532855 0.90 ALDH1A1 (0.81) ALDH1A1LMNAMEN1KMT2ANPC1
SCHEMBL3224084 0.89 ALDH1A1 (0.80) ALDH1A1LMNAMEN1KMT2ANPC1
SCHEMBL6197414 0.89 ALDH1A1 (0.80) ALDH1A1LMNAMEN1KMT2ANPC1
SCHEMBL6423116 0.89 ALDH1A1 (0.80) ALDH1A1LMNAMEN1KMT2ANPC1
SCHEMBL8521100 0.89 ALDH1A1 (0.80) ALDH1A1LMNAMEN1KMT2ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 80 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122036709-A Halogenated anisole-containing side chain dithienyl pyrrole monomer, conjugated polymer, preparation method and application 南阳师范学院 2026-05-15 CN claimed
CN-115425216-B Rambutan-shaped ZnO-N, S double-doped porous carbon composite electrode material and preparation method thereof 邯郸市飞跃炭素有限公司 2025-04-29 CN claimed
CN-115466277-A Carboxyl functionalized time-resolved fluorescent microsphere and preparation method thereof 苏州为度生物技术有限公司 2022-12-13 CN claimed
CN-115425216-A Rambutan-shaped ZnO-N, S double-doped porous carbon composite electrode material and preparation method thereof 深圳市乐汇通科技有限公司 2022-12-02 CN claimed
US-4758312-A Adding colorless electrochemically active compound having positive reduction potential NALCO CHEMICAL COMPANY (US) 1988-07-19 US claimed
JP-3291276-A None JP disclosed
CN-122036709-A Halogenated anisole-containing side chain dithienyl pyrrole monomer, conjugated polymer, preparation method and application 南阳师范学院 2026-05-15 CN disclosed
CN-115425216-B Rambutan-shaped ZnO-N, S double-doped porous carbon composite electrode material and preparation method thereof 邯郸市飞跃炭素有限公司 2025-04-29 CN disclosed
US-11839679-B2 Gamma-diketones for treatment and prevention of aging skin and wrinkles BIOSPLICE THERAPEUTICS, INC. (US) 2023-12-12 US disclosed
US-11839679-B2 Gamma-diketones for treatment and prevention of aging skin and wrinkles BIOSPLICE THERAPEUTICS, INC. (US) 2023-12-12 US disclosed
US-11673885-B2 γ-diketones as Wnt/β-catenin signaling pathway activators BIOSPLICE THERAPEUTICS, INC. (US) 2023-06-13 US disclosed
US-11673885-B2 γ-diketones as Wnt/β-catenin signaling pathway activators BIOSPLICE THERAPEUTICS, INC. (US) 2023-06-13 US disclosed
EP-0454204-A2 Method for the photochemical isomeration of organic compounds under the influence of a photosensitizer DUPHAR INTERNATIONAL RESEARCH B.V (NL) 1991-10-30 EP disclosed
US-4886625-A AROMATIC RESINS MILES INC. (US) 1989-12-12 US disclosed
EP-0322033-A2 New 2,5-diaryl tetrahydrofurans and analogs thereof as paf antagonists MERCK & CO. INC. (US) 1989-06-28 EP disclosed
EP-0314009-A2 Functionalized conductive polymers and their use in diagnostic devices MILES INC. (US) 1989-05-03 EP disclosed
US-4758312-A Adding colorless electrochemically active compound having positive reduction potential NALCO CHEMICAL COMPANY (US) 1988-07-19 US disclosed
EP-0237738-A2 Method for in situ corrosion detection using electrochemically active compounds NALCO CHEMICAL COMPANY (US) 1987-09-23 EP disclosed
US-4683035-A Method for in situ corrosion detection using electrochemically active compounds NALCO CHEMICAL COMPANY (US) 1987-07-28 US disclosed
EP-0199324-A2 New 2,5-diaryl tetryhydrofurans and analogs thereof as paf antagonists MERCK & CO. INC. (US) 1986-10-29 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11839679-B2 Gamma-diketones for treatment and prevention of aging skin and wrinkles DGKG, DGKA, DNER ALDH1A1 1485/4885LMNA 308/4885MEN1 3280/4885
US-11673885-B2 γ-diketones as Wnt/β-catenin signaling pathway activators GSK3A, GSK3B, WNT1 ALDH1A1 1093/4885LMNA 1507/4885MEN1 3158/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.